Delivery Order SPE2DR25D2100-SPE2DR26FA1LY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,214.60 to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Yuvafem 10 microgram vaginal inserts (18 count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 13, 2026. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. AmerisourceBergen Drug Corp is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,563.86 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,197.71 to AmerisourceBergen Drug Corp on August 11, 2025, for Yuvafem 10 mcg vaginal inserts (18-count). This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical...
- The Defense Logistics Agency awarded a $2,696.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Yuvafem 10 microgram vaginal inserts (18 count). This is a non-set-aside contract with performance in Conshohocken, Pennsylvania and an ultimate completion date of January 13, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a $2,496.87 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18 units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 28, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,964.91 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on September 3, 2025, with completion targeted for September 4, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,928.27 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on December 5, 2025, with completion scheduled for December 8, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Yuvafem 10 MCG vaginal insert (18-count) under a firm fixed-price contract with a ceiling value of $1,240.42. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of January 5, 2026. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,170.68 to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Yuvafem 10 microgram vaginal inserts (18-count package). This firm fixed-price, competitively awarded contract carries an ultimate completion date of January 27, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $35,938.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on November 6, 2025, with an ultimate completion date of November 7, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA1LYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $35,054 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 micrograms vaginal insert (18 count) on January 28, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The awardee is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999 through December 2026), which serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates significant capability in fulfilling government medical procurement requirements across multiple therapeutic domains, and the company competes regularly for federal pharmaceutical supply orders through open competition. The DLA Medical Supply Chain relies on vendors like AmerisourceBergen to ensure consistent availability of essential pharmaceuticals and medical commodities for military treatment facilities and defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.1k | 1/27/26 |